Effects of sacubitril/valsartan versus irbesartan in patients with chronic kidney disease: a randomised double-blind trial

<strong>Background</strong> Sacubitril/valsartan reduces the risk of cardiovascular mortality among patients with heart failure with reduced ejection fraction, but its effects on kidney function and cardiac biomarkers in people with moderate-to-severe chronic kidney disease are unknown....

সম্পূর্ণ বিবরণ

গ্রন্থ-পঞ্জীর বিবরন
প্রধান লেখক: Haynes, R, Judge, P, Staplin, N, Herrington, W, Storey, B, Bethel, A, Bowman, L, Brunskill, N, Cockwell, P, Hill, M, Kalra, P, McMurray, J, Taal, M, Wheeler, D, Landray, M, Baigent, C, UK HARP-III Collaborative Group
বিন্যাস: Journal article
প্রকাশিত: American Heart Association 2018
বিষয়গুলি: